Luis Diaz
MD
Head, Division of Solid Tumor Oncology
👥Biography 个人简介
Luis Diaz conducted the seminal clinical trial demonstrating that PD-1 blockade produces durable responses in MSI-H cancers regardless of tissue of origin, leading to the first tissue-agnostic FDA approval. His work on circulating tumor DNA as a biomarker has advanced liquid biopsy applications in CRC. He is a transformative figure in precision immuno-oncology.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Luis Diaz 的研究动态
Follow Luis Diaz's research updates
留下邮箱，当我们发布与 Luis Diaz（Memorial Sloan Kettering Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment